ArticleOncotarget2021

Phase 1 study of Z-endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumors.

Naoko Takebe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.